Home/BioGenCell/Sharon Cohen
SC

Sharon Cohen

VP R&D

BioGenCell

BioGenCell Pipeline

DrugIndicationPhase
BGC101Chronic Limb‑Threatening Ischemia (CLTI)Phase 2
BGC10XBroad Microvascular Unmet NeedsPreclinical